GENE - Genetic Technologies Limited

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
1.48
+0.39 (+35.78%)
At close: 4:00PM EDT

1.45 -0.03 (-2.03%)
After hours: 4:35PM EDT

Stock chart is not supported by your current browser
Previous Close1.09
Open1.44
Bid1.45 x 1300
Ask1.48 x 1000
Day's Range1.38 - 2.04
52 Week Range0.70 - 2.05
Volume24,558,416
Avg. Volume57,458
Market Cap25.312M
Beta4.09
PE Ratio (TTM)N/A
EPS (TTM)-0.30
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est12.50
Trade prices are not sourced from all markets
  • Genetic Technologies Stock Up on Genetic Test Update
    Market Realist3 hours ago

    Genetic Technologies Stock Up on Genetic Test Update

    Today, Genetic Technologies (GENE) was trading over 70% higher than yesterday’s closing price of $1.09. The stock jumped ~72.5% in premarket trading. The stock price and volumes rose on the news of the company’s on-track breast cancer and colorectal cancer risk assessment tests, slated for release in October.

  • Benzinga7 hours ago

    Benzinga Pro's 5 Stocks To Watch Today

    Each day, the Benzinga Pro news team highlights several stocks with Trading Idea potential. Be the first to see them by becoming a Benzinga Pro user ! Coda Octopus Group, Inc. (NASDAQ: CODA ) stock soared ...

  • GlobeNewswire11 hours ago

    Genetic Technologies Limited Announces Expansion of Genetic Risk Assessment Tests and October Launch of New Breast Cancer and Colorectal Cancer Tests

    MELBOURNE, Australia, July 16, 2018-- Genetic Technologies Limited, a diversified molecular diagnostics company embracing blockchain technologies across genomic testing platforms, announced today that ...

  • GlobeNewswire27 days ago

    Genetic Technologies Announces Heads of Agreement with Swisstec

    Genetic Technologies Limited (ASX:GTG) (GENE) (“Company”, “GTG”), a diversified molecular diagnostics company embracing blockchain technologies across genomic testing platforms, is pleased to announce that it has entered into a Heads of Agreement with Swisstec Health Analytics Ltd. (“Swisstec”) to work together over the next 30 days to finalise a Proposed Joint Venture (PJV) to establish a new Company, (“JV Company”). The JV Company will enable both companies to collaborate to develop a service platform using blockchain technology that will provide a marketplace for medical services and personalised health management, and will also facilitate data management and AI-based services to promote better patient outcomes.

  • GlobeNewswirelast month

    Genetic Technologies Announces Binding Project Shivom Agreement

    Project Shivom to provide GTG access to a significant pool of data, particularly related to the Indian population. GTG, through access to the Indian population data to modify its risk assessment kits as well as to develop new Indian specific tests or products, including tests related to diabetes and other disease, based on opportunity and areas of need.

  • Investopedia2 months ago

    Why KISS Rocker Gene Simmons Sees Dow 30,000

    Beyond 30,000, that’s where the Dow Jones Industrial Average (DJIA) is headed, according to Gene Simmons, known by many rock n’ roll fans as the KISS Demon. As of the close of trading on Tuesday, the Dow was sitting around 24,360, down 1.5% on the year. Since 1985, the Dow has gone through good times and bad, but has risen overall by nearly 1,800%.

  • GlobeNewswire2 months ago

    Genetic Technologies Announces Grant from NHMRC Awarded to University of Melbourne to Substantially Improve Breast Cancer Risk Prediction and Increase Accessibility 

    Genetic Technologies Limited (ASX:GTG) (GENE) (“Company”), a diversified molecular diagnostics company embracing blockchain technologies across genomic testing platforms, is pleased to announce the award of an NHMRC Partnership Grant to a research team led by Professor John Hopper from the Centre for Epidemiology and Biostatistics, Melbourne School of Population & Global Health at The University of Melbourne.

  • Invictus MD Strategies Corp. Opens the Market
    CNW Group4 months ago

    Invictus MD Strategies Corp. Opens the Market

    Invictus MD Strategies Corp. Opens the Market

  • PR Newswire4 months ago

    Invictus MD Strategies Corp. Opens the Market

    TORONTO , March 20, 2018 /CNW/ - Dan Kriznic , Chairman, CEO, Founder & Director, alongside Gene Simmons , Co-Founder of KISS, and Chief Evangelist Officer, Invictus MD Strategies Corp. (GENE), joined ...

  • PR Newswire4 months ago

    Shivom Partnership With Genetic Technologies Will Enable Better Cancer Prediction and Prevention Through Mass Genomic Data Analysis

    NASDAQ: GENE) to accelerate the prediction of cancer for millions of individuals worldwide. GTG, whose lead product is BREVAGenplus® - a clinically validated risk assessment test for non-hereditary breast cancer - is at the forefront of preventive medicine.

  • Benzinga6 months ago

    Benzinga Pro's 5 Stocks To Watch Today

    Each day, the Benzinga Pro news team highlights several stocks with Trading Idea potential. Be the first to see them by becoming a Benzinga Pro user ! Helios and Matheson Analytics Inc (NASDAQ: HMNY ) ...

  • ACCESSWIRE9 months ago

    Today's Research Reports on Stocks to Watch: Tetraphase Pharmaceuticals and Genetic Technologies

    NEW YORK, NY / ACCESSWIRE / October 5, 2017 / Shares of Tetraphase Pharma and Genetic Technologies both climbed higher on Wednesday. Despite any news to serve as a catalyst for the gains, shares of Genetic ...